Literature DB >> 12494333

Dihydroisotanshinone I protects against menadione-induced toxicity in a primary culture of rat hepatocytes.

Siu-Po Ip1, Hui Yang, Han-Dong Sun, Chun-Tao Che.   

Abstract

Dihydroisotanshinone I is a phenanthrenequinone derivative isolated from the roots of Salvia trijuga Diels. The present study demonstrated the hepatoprotective effect of dihydroisotanshinone I against menadione-induced cytotoxicity in a primary culture of rat hepatocytes. Pretreating the cells with dihydroisotanshinone I at concentrations ranging from 2.5 microM to 20 microM for 24 hours caused dose-dependent protection against hepatotoxicity induced by menadione. Intracellular glutathione level and activity of DT-diaphorase have been suggested to play important roles in menadione-induced cytotoxicity. However, treating the hepatocytes with 20 microM dihydroisotanshinone I for 24 hours did not cause a significant change in glutathione level and DT-diaphorase activity. On the contrary, adding dihydroisotanshinone I to freshly isolated hepatocytes at concentrations between 50 nM to 200 nM inhibited NADH-induced superoxide production dose-dependently as indicated by the decrease of lucigenin-amplified chemiluminescence. In addition, dihydroisotanshinone I at concentrations ranging from 5 microM to 20 microM inhibited tert-butyl hydroperoxide-induced lipid peroxidation dose-dependently in isolated hepatocytes as indicated by the level of malondialdehyde. These results suggest that the protective action of dihydroisotanshinone I against menadione-induced hepatotoxicity is attributed to its antioxidant properties including the free radical scavenging activity and inhibition of lipid peroxidation. Abbreviations. DTD:DT-diaphorase GSH:glutathione LDH:lactate dehydrogenase MDA:malondialdehyde MTT:3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide TBHP: tert-butyl hydroperoxide

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12494333     DOI: 10.1055/s-2002-36345

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  1 in total

1.  Anti-cancer effect of danshen and dihydroisotanshinone I on prostate cancer: targeting the crosstalk between macrophages and cancer cells via inhibition of the STAT3/CCL2 signaling pathway.

Authors:  Ching-Yuan Wu; Yao-Hsu Yang; Yin-Yin Lin; Feng-Che Kuan; Yu-Shin Lin; Wei-Yu Lin; Ming-Yen Tsai; Jia-Jing Yang; Yu-Ching Cheng; Li-Hsin Shu; Ming-Chu Lu; Yun-Ju Chen; Kuan-Der Lee; Hong-Yo Kang
Journal:  Oncotarget       Date:  2017-06-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.